Table 4.
An adult with incidentally discovered asymptomatic thrombocytopenia
| Management choice | Responses | Years in practice | ||
|---|---|---|---|---|
| <5 | 5–20 | >20 | ||
| Anti-D (Win-Rho) | 0 | 0 | 0 | 0 |
| Corticosteroids (daily oral prednisone) | 5 | 1 | 3 | 1 |
| Corticosteroids (intermittent high-dose dexamethasone) | 0 | 0 | 0 | 0 |
| IVIg | 0 | 0 | 0 | 0 |
| Observation with no drug treatment (“watchful waiting”) | 77 | 23 | 27 | 27 |
| Rituximab | 0 | 0 | 0 | 0 |
| Thrombopoietin Receptor Agonists (Nplate [romiplostim], Promacta [eltrombopag]) | 0 | 0 | 0 | 0 |
| Other (describe): __________________ | 0 | 0 | 0 | 0 |
Survey question 1. An active healthy, non-pregnant 28 year-old woman is discovered on a routine evaluation to have a platelet count of 40,000/μl. She has no symptoms of bruising and her menstrual periods have been normal. Her complete blood count and smear review are otherwise normal, and her blood group is A+. What is your management choice?
No strong recommendations by either the ICR8 or the ASH9 guideline